Ophthotech Corp Company Profile (NASDAQ:OPHT)

About Ophthotech Corp (NASDAQ:OPHT)

Ophthotech Corp logoOphthotech Corporation is a biopharmaceutical company. The Company is engaged in the development of therapeutics to treat ophthalmic diseases, with a focus on diseases of the back of the eye. Its primary focus is developing therapeutics for age-related macular degeneration (AMD), which is a disorder of the central portion of the retina, known as the macula, that may result in blindness. Its product candidates include Fovista and Zimura. Fovista is designed to target platelet derived growth factor (PDGF) in combination with anti-vascular endothelial growth factor (VEGF) drugs to disrupt the formation of abnormal new blood vessels in wet AMD. Zimura targets complement factor C5, a central component of the complement cascade. The Company has initiated a Phase II/III clinical trial investigating Zimura for treatment of geographic atrophy.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Symbol: NASDAQ:OPHT
  • CUSIP: N/A
  • Web: www.ophthotech.com
Capitalization:
  • Market Cap: $83.89 million
  • Outstanding Shares: 35,852,000
Average Prices:
  • 50 Day Moving Avg: $2.75
  • 200 Day Moving Avg: $9.12
  • 52 Week Range: $2.26 - $65.96
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.00
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $36.85 million
  • Price / Sales: 2.28
  • Book Value: ($3.67) per share
  • Price / Book: -0.64
Profitability:
  • EBIDTA: ($192,210,000.00)
  • Net Margins: -323.19%
  • Return on Equity: -916.07%
  • Return on Assets: -41.63%
Debt:
  • Current Ratio: 6.07%
  • Quick Ratio: 6.07%
Misc:
  • Average Volume: 1.00 million shs.
  • Beta: 1.85
  • Short Ratio: 4.06
 

Frequently Asked Questions for Ophthotech Corp (NASDAQ:OPHT)

What is Ophthotech Corp's stock symbol?

Ophthotech Corp trades on the NASDAQ under the ticker symbol "OPHT."

How were Ophthotech Corp's earnings last quarter?

Ophthotech Corp (NASDAQ:OPHT) announced its quarterly earnings data on Wednesday, May, 3rd. The company reported ($1.20) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.31) by $0.11. The business had revenue of $1.66 million for the quarter, compared to the consensus estimate of $1.94 million. Ophthotech Corp had a negative net margin of 323.19% and a negative return on equity of 916.07%. View Ophthotech Corp's Earnings History.

When will Ophthotech Corp make its next earnings announcement?

Ophthotech Corp is scheduled to release their next quarterly earnings announcement on Tuesday, August, 1st 2017. View Earnings Estimates for Ophthotech Corp.

Where is Ophthotech Corp's stock going? Where will Ophthotech Corp's stock price be in 2017?

12 analysts have issued 1 year price targets for Ophthotech Corp's stock. Their forecasts range from $11.00 to $92.00. On average, they expect Ophthotech Corp's share price to reach $59.11 in the next twelve months. View Analyst Ratings for Ophthotech Corp.

Who are some of Ophthotech Corp's key competitors?

Who are Ophthotech Corp's key executives?

Ophthotech Corp's management team includes the folowing people:

  • David R. Guyer M.D., Executive Chairman of the Board
  • Glenn P. Sblendorio, President, Chief Executive Officer
  • David Carroll, Chief Financial Officer, Senior Vice President, Treasurer
  • Keith Westby, Chief Operating Officer, Senior Vice President
  • Barbara A. Wood Esq., Senior Vice President, General Counsel, Secretary
  • Kathy Galante, Vice President of Investor Relations and Corporate Communications
  • David E. Redlick, Director
  • Ian F. Smith CPA, Director
  • Axel Bolte, Independent Director
  • Thomas Dyrberg M.D., Independent Director

Who owns Ophthotech Corp stock?

Ophthotech Corp's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Stonepine Capital Management LLC (9.82%), Vanguard Group Inc. (7.86%), Morgan Stanley (6.23%), Renaissance Technologies LLC (5.19%), Bogle Investment Management L P DE (3.10%) and Acadian Asset Management LLC (1.65%). Company insiders that own Ophthotech Corp stock include A/S Novo, Axel Bolte, Barbara A Wood, David R Guyer, Glenn Sblendorio, Henric Bjorn Bjarke, Nicholas Galakatos and Samir Chandrakant Patel. View Institutional Ownership Trends for Ophthotech Corp.

Who sold Ophthotech Corp stock? Who is selling Ophthotech Corp stock?

Ophthotech Corp's stock was sold by a variety of institutional investors in the last quarter, including Prescott Group Capital Management L.L.C., Bogle Investment Management L P DE, Tudor Investment Corp ET AL, Wells Fargo & Company MN, TIAA CREF Investment Management LLC, Teachers Advisors LLC, Alliancebernstein L.P. and California Public Employees Retirement System. Company insiders that have sold Ophthotech Corp stock in the last year include A/S Novo, Barbara A Wood, David R Guyer, Glenn Sblendorio, Henric Bjorn Bjarke and Samir Chandrakant Patel. View Insider Buying and Selling for Ophthotech Corp.

Who bought Ophthotech Corp stock? Who is buying Ophthotech Corp stock?

Ophthotech Corp's stock was purchased by a variety of institutional investors in the last quarter, including Morgan Stanley, Renaissance Technologies LLC, Stonepine Capital Management LLC, Acadian Asset Management LLC, Quantitative Investment Management LLC, Oxford Asset Management, Thrivent Financial For Lutherans and Canada Pension Plan Investment Board. View Insider Buying and Selling for Ophthotech Corp.

How do I buy Ophthotech Corp stock?

Shares of Ophthotech Corp can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Ophthotech Corp's stock price today?

One share of Ophthotech Corp stock can currently be purchased for approximately $2.34.


MarketBeat Community Rating for Ophthotech Corp (NASDAQ OPHT)
Community Ranking:  3.3 out of 5 (  )
Outperform Votes:  181 (Vote Outperform)
Underperform Votes:  94 (Vote Underperform)
Total Votes:  275
MarketBeat's community ratings are surveys of what our community members think about Ophthotech Corp and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Ophthotech Corp (NASDAQ:OPHT) (?)
Ratings Breakdown: 12 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $59.11 (2,426.12% upside)

Analysts' Ratings History for Ophthotech Corp (NASDAQ:OPHT)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
12/13/2016GabelliDowngradeBuy -> HoldN/AView Rating Details
12/13/2016Morgan StanleyDowngradeOverweight -> Equal WeightN/AView Rating Details
12/12/2016Goldman Sachs Group IncUpgradeSell -> NeutralN/AView Rating Details
12/12/2016Leerink SwannDowngradeOutperform -> Market PerformN/AView Rating Details
12/12/2016Stifel NicolausDowngradeBuy -> HoldN/AView Rating Details
12/12/2016BTIG ResearchDowngradeBuy -> NeutralN/AView Rating Details
12/12/2016Cowen and CompanyDowngradeOutperform -> Market PerformN/AView Rating Details
12/12/2016Citigroup IncDowngradeBuy -> NeutralN/AView Rating Details
12/12/2016Barclays PLCDowngradeOverweight -> Equal WeightN/AView Rating Details
12/12/2016JPMorgan Chase & Co.DowngradeOverweight -> Neutral$11.00N/AView Rating Details
12/12/2016SunTrust Banks, Inc.DowngradeBuy -> HoldN/AView Rating Details
12/12/2016Chardan CapitalDowngradeBuy -> Neutral$15.00N/AView Rating Details
11/19/2015Oppenheimer Holdings Inc.Reiterated RatingOutperform$95.00N/AView Rating Details
(Data available from 5/29/2015 forward)

Earnings

Earnings History for Ophthotech Corp (NASDAQ:OPHT)
Earnings by Quarter for Ophthotech Corp (NASDAQ:OPHT)
Earnings History by Quarter for Ophthotech Corp (NASDAQ:OPHT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/1/2017        
5/3/2017Q1 2017($1.31)($1.20)$1.94 million$1.66 millionViewListenView Earnings Details
11/8/2016Q316($1.64)($1.71)$6.20 million$1.67 millionViewListenView Earnings Details
8/3/2016Q216($1.05)($0.85)$18.64 million$28.20 millionViewListenView Earnings Details
5/4/2016Q116($1.33)($1.03)$7.22 million$15.70 millionViewListenView Earnings Details
2/24/2016Q415($1.35)($1.02)$7.59 million$4.78 millionViewListenView Earnings Details
11/5/2015Q315($0.98)($1.14)$11.31 million$3.40 millionViewN/AView Earnings Details
8/5/2015Q215($1.02)($1.08)$2.77 million$1.60 millionViewN/AView Earnings Details
5/11/2015Q115($0.75)$0.22$3.68 million$41.70 millionViewListenView Earnings Details
2/23/2015Q414($0.57)($1.06)$12.36 million$1.68 millionViewN/AView Earnings Details
11/11/2014Q314($0.62)$0.31$8.02 million$39.58 millionViewN/AView Earnings Details
8/6/2014Q214($0.56)($1.57)$4.31 millionViewN/AView Earnings Details
5/13/2014Q1($0.67)($0.64)ViewListenView Earnings Details
2/27/2014($0.50)($0.65)ViewN/AView Earnings Details
11/13/2013Q313($1.00)($10.26)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Ophthotech Corp (NASDAQ:OPHT)
2017 EPS Consensus Estimate: ($4.63)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($1.45)($1.45)($1.45)
Q2 20172($1.19)($1.14)($1.17)
Q3 20172($1.13)($1.04)($1.09)
Q4 20172($1.07)($0.79)($0.93)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Ophthotech Corp (NASDAQ:OPHT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Ophthotech Corp (NASDAQ:OPHT)
Insider Ownership Percentage: 2.00%
Institutional Ownership Percentage: 95.66%
Insider Trades by Quarter for Ophthotech Corp (NASDAQ:OPHT)
Institutional Ownership by Quarter for Ophthotech Corp (NASDAQ:OPHT)
Insider Trades by Quarter for Ophthotech Corp (NASDAQ:OPHT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/3/2017Glenn SblendorioCFOSell7,388$3.56$26,301.28View SEC Filing  
1/5/2017David R GuyerCEOSell3,785$4.96$18,773.60View SEC Filing  
1/5/2017Henric Bjorn BjarkeSVPSell316$4.96$1,567.36View SEC Filing  
1/5/2017Samir Chandrakant PatelPresidentSell3,844$4.96$19,066.24View SEC Filing  
1/3/2017Barbara A WoodSVPSell675$4.90$3,307.50View SEC Filing  
1/3/2017David R GuyerCEOSell3,484$4.90$17,071.60View SEC Filing  
1/3/2017Samir Chandrakant PatelPresidentSell2,999$4.90$14,695.10View SEC Filing  
12/23/2016Barbara A. WoodSVPSell746$4.92$3,670.32View SEC Filing  
12/22/2016Glenn SblendorioCFOSell1,079$4.85$5,233.15View SEC Filing  
12/15/2016A/S NovoMajor ShareholderSell3,610,487$4.87$17,583,071.69View SEC Filing  
11/1/2016David R GuyerCEOSell22,060$35.61$785,556.60View SEC Filing  
10/3/2016David R GuyerCEOSell22,060$44.37$978,802.20View SEC Filing  
9/29/2016Samir Chandrakant PatelPresidentSell20,000$55.17$1,103,400.00View SEC Filing  
8/29/2016Samir Chandrakant PatelPresidentSell20,000$52.80$1,056,000.00View SEC Filing  
8/1/2016David R GuyerCEOSell24,060$64.47$1,551,148.20View SEC Filing  
7/29/2016Samir Chandrakant PatelPresidentSell20,000$64.21$1,284,200.00View SEC Filing  
7/1/2016David R GuyerCEOSell24,060$52.12$1,254,007.20View SEC Filing  
6/30/2016Samir Chandrakant PatelPresidentSell41,846$51.23$2,143,770.58View SEC Filing  
6/3/2016Axel BolteDirectorBuy3,500$56.97$199,395.00View SEC Filing  
6/2/2016Glenn SblendorioCFOSell671$57.20$38,381.20View SEC Filing  
6/1/2016David R GuyerCEOSell30,060$52.71$1,584,462.60View SEC Filing  
5/31/2016Samir Chandrakant PatelPresidentSell20,000$53.32$1,066,400.00View SEC Filing  
5/24/2016A/S NovoMajor ShareholderSell1,300,000$49.00$63,700,000.00View SEC Filing  
5/2/2016David R GuyerCEOSell22,060$46.18$1,018,730.80View SEC Filing  
4/29/2016Samir Chandrakant PatelPresidentSell20,000$46.79$935,800.00View SEC Filing  
4/1/2016David R GuyerCEOSell22,060$44.11$973,066.60View SEC Filing  
3/29/2016Samir Chandrakant PatelPresidentSell20,000$41.85$837,000.00View SEC Filing  
3/1/2016David R GuyerCEOSell22,060$45.48$1,003,288.80View SEC Filing  
2/29/2016Samir Chandrakant PatelPresidentSell20,000$45.13$902,600.00View SEC Filing  
1/29/2016Samir Chandrakant PatelPresidentSell20,000$53.59$1,071,800.00View SEC Filing  
1/28/2016David R. GuyerCEOSell18,598$53.63$997,410.74View SEC Filing  
1/11/2016Nicholas GalakatosDirectorSell3,000$65.72$197,160.00View SEC Filing  
1/4/2016Barbara A. WoodSVPSell1,000$76.37$76,370.00View SEC Filing  
12/30/2015David R. GuyerCEOSell18,582$78.82$1,464,633.24View SEC Filing  
12/30/2015Glenn SblendorioDirectorSell2,000$80.00$160,000.00View SEC Filing  
12/29/2015Samir Chandrakant PatelPresidentSell1,184$77.50$91,760.00View SEC Filing  
12/24/2015Samir Chandrakant PatelPresidentSell26,036$77.09$2,007,115.24View SEC Filing  
12/10/2015Nicholas GalakatosDirectorSell3,000$64.44$193,320.00View SEC Filing  
12/1/2015Barbara A. WoodSVPSell2,000$63.24$126,480.00View SEC Filing  
11/30/2015David R. GuyerCEOSell18,582$62.49$1,161,189.18View SEC Filing  
11/24/2015Samir Chandrakant PatelPresidentSell27,215$60.27$1,640,248.05View SEC Filing  
11/18/2015Nicholas GalakatosDirectorSell1,500$60.00$90,000.00View SEC Filing  
11/5/2015Samir Chandrakant PatelPresidentSell20,687$53.55$1,107,788.85View SEC Filing  
10/21/2015Samir Chandrakant PatelPresidentSell27,215$43.27$1,177,593.05View SEC Filing  
10/16/2015Barbara A. WoodSVPSell2,000$45.00$90,000.00View SEC Filing  
9/29/2015David R. GuyerCEOSell18,582$37.69$700,355.58View SEC Filing  
9/21/2015Samir Chandrakant PatelPresidentSell27,215$46.34$1,261,143.10View SEC Filing  
8/31/2015David R. GuyerCEOSell18,582$44.88$833,960.16View SEC Filing  
8/20/2015Samir Chandrakant PatelPresidentSell27,215$48.75$1,326,731.25View SEC Filing  
7/20/2015Samir Chandrakant PatelPresidentSell27,215$67.87$1,847,082.05View SEC Filing  
7/17/2015Glenn SblendorioDirectorSell3,000$67.33$201,990.00View SEC Filing  
7/1/2015Barbara A WoodSVPSell2,000$51.94$103,880.00View SEC Filing  
6/29/2015David R GuyerCEOSell18,582$51.05$948,611.10View SEC Filing  
6/18/2015Samir Chandrakant PatelPresidentSell12,000$49.78$597,360.00View SEC Filing  
5/28/2015David R GuyerCEOSell18,582$48.62$903,456.84View SEC Filing  
4/29/2015David R GuyerCEOSell18,582$48.45$900,297.90View SEC Filing  
4/17/2015Samir Chandrakant PatelPresidentSell12,000$50.47$605,640.00View SEC Filing  
3/30/2015Axel BolteDirectorBuy500$48.27$24,135.00View SEC Filing  
3/30/2015David R GuyerCEOSell18,582$48.26$896,767.32View SEC Filing  
3/2/2015Barbara A WoodSVPSell2,000$53.26$106,520.00View SEC Filing  
3/2/2015David R GuyerCEOSell18,582$53.22$988,934.04View SEC Filing  
1/2/2015David R GuyerCEOSell15,034$45.34$681,641.56View SEC Filing  
11/13/2014A/S NovoMajor ShareholderSell995,000$40.20$39,999,000.00View SEC Filing  
11/3/2014David R GuyerCEOSell15,034$39.71$597,000.14View SEC Filing  
10/2/2014David R GuyerCEOSell2,807$38.52$108,125.64View SEC Filing  
10/2/2014Samir Chandrakant PatelPresidentSell1,965$38.04$74,748.60View SEC Filing  
10/1/2014David R GuyerCEOSell12,227$37.30$456,067.10View SEC Filing  
10/1/2014Samir Chandrakant PatelPresidentSell17,676$37.28$658,961.28View SEC Filing  
9/4/2014David R GuyerCEOSell1,107$38.58$42,708.06View SEC Filing  
8/1/2014Bruce PeacockCFOSell6,191$37.78$233,895.98View SEC Filing  
8/1/2014David R GuyerCEOSell13,136$37.85$497,197.60View SEC Filing  
8/1/2014Samir Chandrakant PatelPresidentSell18,986$37.80$717,670.80View SEC Filing  
7/1/2014Bruce PeacockCFOSell7,739$41.07$317,840.73View SEC Filing  
7/1/2014David R GuyerCEOSell15,034$41.08$617,596.72View SEC Filing  
7/1/2014Samir Chandrakant PatelPresidentSell18,986$41.08$779,944.88View SEC Filing  
6/16/2014Nicholas GalakatosDirectorSell144,976$44.17$6,403,589.92View SEC Filing  
6/11/2014Lifesciences Ii L.P. ClarusMajor ShareholderSell211,680$45.42$9,614,505.60View SEC Filing  
6/4/2014Svlsf Iv, LlcMajor ShareholderSell1,966,935$42.54$83,673,414.90View SEC Filing  
6/3/2014Bruce PeacockCFOSell13,931$40.12$558,911.72View SEC Filing  
6/3/2014Svlsf Iv, LlcMajor ShareholderSell1,865,619$40.65$75,837,412.35View SEC Filing  
6/2/2014David R GuyerCEOSell25,417$39.92$1,014,646.64View SEC Filing  
6/2/2014Samir Chandrakant PatelPresidentSell27,873$39.91$1,112,411.43View SEC Filing  
5/30/2014Svlsf Iv, LlcMajor ShareholderSell931,869$40.99$38,197,310.31View SEC Filing  
5/28/2014Svlsf Iv, LlcMajor ShareholderSell980,127$40.19$39,391,304.13View SEC Filing  
5/23/2014Svlsf Iv, LlcMajor ShareholderSell330,450$38.10$12,590,145.00View SEC Filing  
5/13/2014Hbm Healthcare Investments (Camajor shareholderSell500,000$29.75$14,875,000.00View SEC Filing  
5/1/2014Bruce PeacockCFOSell4,643$32.43$150,572.49View SEC Filing  
5/1/2014David GuyerCEOSell10,665$33.71$359,517.15View SEC Filing  
5/1/2014Samir Chandrakant PatelPresidentSell14,319$32.45$464,651.55View SEC Filing  
3/24/2014Bruce PeacockCFOSell6,137$34.77$213,383.49View SEC Filing  
3/24/2014David GuyerCEOSell12,027$34.53$415,292.31View SEC Filing  
3/24/2014Samir Chandrakant PatelPresidentSell16,876$34.54$582,897.04View SEC Filing  
2/18/2014Svlsf Iv, Llcmajor shareholderSell2,111,364$29.61$62,517,488.04View SEC Filing  
9/30/2013A/S NovoInsiderBuy455,000$22.00$10,010,000.00View SEC Filing  
9/30/2013Hbm Healthcare Investments (CaMajor ShareholderBuy228,000$22.00$5,016,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Ophthotech Corp (NASDAQ:OPHT)
Latest Headlines for Ophthotech Corp (NASDAQ:OPHT)
Source:
DateHeadline
prnewswire.com logoBiotech Stocks on Investors' Radar -- Ophthotech, Pacific Biosciences of California, PTC Therapeutics, and Portola ... - PR Newswire (press release)
www.prnewswire.com - May 24 at 10:15 AM
reuters.com logoBRIEF-David Shaw reports a 5 pct passive stake in Ophthotech Corp as of May 11 ...
www.reuters.com - May 22 at 6:15 PM
businesswire.com logoNewman Ferrara LLP Announces Corporate Governance Investigation of Ophthotech Corp. - OPHT - Business Wire (press release)
www.businesswire.com - May 16 at 11:46 PM
finance.yahoo.com logoNewman Ferrara LLP Announces Corporate Governance Investigation of Ophthotech Corp. - OPHT
finance.yahoo.com - May 16 at 10:02 AM
americanbankingnews.com logoOphthotech Corp (OPHT) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - May 15 at 4:41 PM
americanbankingnews.com logoFY2018 EPS Estimates for Ophthotech Corp Raised by Gabelli (OPHT)
www.americanbankingnews.com - May 8 at 11:54 AM
americanbankingnews.com logoLeerink Swann Analysts Increase Earnings Estimates for Ophthotech Corp (OPHT)
www.americanbankingnews.com - May 8 at 8:15 AM
americanbankingnews.com logoOphthotech Corp (OPHT) Expected to Announce Quarterly Sales of $1.68 Million
www.americanbankingnews.com - May 6 at 9:52 AM
americanbankingnews.com logoOphthotech Corp (OPHT) Releases Earnings Results, Beats Estimates By $0.11 EPS
www.americanbankingnews.com - May 6 at 1:00 AM
americanbankingnews.com logoOphthotech Corp (OPHT) Posts Earnings Results, Beats Estimates By $0.11 EPS
www.americanbankingnews.com - May 5 at 11:53 PM
americanbankingnews.com logoQ2 2017 EPS Estimates for Ophthotech Corp (OPHT) Increased by Analyst
www.americanbankingnews.com - May 5 at 8:24 AM
americanbankingnews.com logoOphthotech Corp (OPHT) Receives Coverage Optimism Rating of 0.14
www.americanbankingnews.com - May 4 at 9:58 PM
americanbankingnews.com logoOphthotech Corp (OPHT) Expected to Announce Earnings of -$1.31 Per Share
www.americanbankingnews.com - May 4 at 7:52 AM
seekingalpha.com logoOphthotech's (OPHT) CEO David Guyer on Q1 2017 Results - Earnings Call Transcript
seekingalpha.com - May 4 at 1:02 AM
finance.yahoo.com logoEdited Transcript of OPHT earnings conference call or presentation 3-May-17 12:00pm GMT
finance.yahoo.com - May 4 at 1:02 AM
finance.yahoo.com logoInvestor Network: Ophthotech Corp. to Host Earnings Call
finance.yahoo.com - May 3 at 8:00 PM
finance.yahoo.com logoOphthotech Reports First Quarter 2017 Financial and Operating Results
finance.yahoo.com - May 3 at 8:00 PM
finance.yahoo.com logoOphthotech reports 1Q loss
finance.yahoo.com - May 3 at 8:00 PM
americanbankingnews.com logoOphthotech Corp (OPHT) Upgraded by Zacks Investment Research to "Buy"
www.americanbankingnews.com - May 2 at 1:56 PM
finance.yahoo.com logoETFs with exposure to Ophthotech Corp. : May 1, 2017
finance.yahoo.com - May 1 at 5:59 PM
americanbankingnews.com logoOphthotech Corp (OPHT) Receiving Somewhat Critical News Coverage, Report Finds
www.americanbankingnews.com - May 1 at 3:44 PM
americanbankingnews.com logoOphthotech Corp (OPHT) Earns Media Impact Score of 0.20
www.americanbankingnews.com - April 27 at 3:36 PM
finance.yahoo.com logoOphthotech Corporation to Report First Quarter 2017 Financial Results and Host Conference Call on Wednesday, May ... - Yahoo Finance
finance.yahoo.com - April 27 at 10:14 AM
finance.yahoo.com logoOphthotech Corporation to Report First Quarter 2017 Financial Results and Host Conference Call on Wednesday, May 3, 2017
finance.yahoo.com - April 26 at 6:15 PM
reuters.com logoBRIEF-Ophthotech says Glenn Sblendorio to become chief executive officer
www.reuters.com - April 25 at 6:14 PM
streetinsider.com logoOphthotech Corp (OPHT) CEO to Transition to Executive Chairman; Glenn P. Sblendorio Named CEO
www.streetinsider.com - April 25 at 6:14 PM
streetinsider.com logoOphthotech Corp (OPHT) CEO to Transition to Executive Chairman; Glenn P. Sblendorio Named CEO - StreetInsider.com
www.streetinsider.com - April 25 at 11:26 AM
finance.yahoo.com logoOphthotech Announces Leadership Transition Effective July 1, 2017
finance.yahoo.com - April 24 at 4:58 PM
americanbankingnews.com logoOphthotech Corp (OPHT) Earning Positive Media Coverage, Analysis Finds
www.americanbankingnews.com - April 24 at 4:56 PM
americanbankingnews.com logoOphthotech Corp (OPHT) Short Interest Down 13.8% in March
www.americanbankingnews.com - April 21 at 8:45 PM
americanbankingnews.com logoSomewhat Negative Press Coverage Extremely Likely to Impact Ophthotech Corp (OPHT) Share Price
www.americanbankingnews.com - April 21 at 5:50 PM
finance.yahoo.com logoETFs with exposure to Ophthotech Corp. : April 19, 2017
finance.yahoo.com - April 19 at 7:04 PM
americanbankingnews.com logoOphthotech Corp (OPHT) Earning Somewhat Critical Media Coverage, Study Finds
www.americanbankingnews.com - April 17 at 5:03 PM
americanbankingnews.com logo$1.94 Million in Sales Expected for Ophthotech Corp (OPHT) This Quarter
www.americanbankingnews.com - April 15 at 9:55 AM
americanbankingnews.com logoOphthotech Corp (OPHT) Getting Somewhat Favorable Media Coverage, Report Finds
www.americanbankingnews.com - April 13 at 3:50 PM
americanbankingnews.com logo Analysts Anticipate Ophthotech Corp (OPHT) Will Announce Earnings of -$1.31 Per Share
www.americanbankingnews.com - April 13 at 8:48 AM
finance.yahoo.com logoETFs with exposure to Ophthotech Corp. : April 7, 2017
finance.yahoo.com - April 7 at 7:26 PM
americanbankingnews.com logoInsider Selling: Ophthotech Corp (OPHT) CFO Sells 7,388 Shares of Stock
www.americanbankingnews.com - April 4 at 10:58 PM
biz.yahoo.com logoOPHTHOTECH CORP. Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders
biz.yahoo.com - March 31 at 8:56 AM
finance.yahoo.com logoOphthotech (OPHT) Down 2.9% Since Earnings Report: Can It Rebound?
finance.yahoo.com - March 31 at 8:56 AM
americanbankingnews.com logoOphthotech Corp's (OPHT) "Market Perform" Rating Reaffirmed at Leerink Swann
www.americanbankingnews.com - March 27 at 4:34 PM
seekingalpha.com logoBuy Ophthotech, Get Cash And Zimura For Free
seekingalpha.com - March 25 at 6:39 PM
benzinga.com logoDo Analysts See A Path Forward For Ophthotech's Fovista?
www.benzinga.com - March 24 at 11:57 PM
americanbankingnews.com logoOphthotech Corp (OPHT) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - March 24 at 1:04 PM
businesswire.com logoOPHTHOTECH 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action ...
www.businesswire.com - March 11 at 2:00 AM
finance.yahoo.com logoOPHTHOTECH 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit against Ophthotech Corporation – (OPHT)
finance.yahoo.com - March 11 at 2:00 AM
finance.yahoo.com logoEQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Ophthotech Corporation and Encourages Investors with Losses to Contact the Firm
finance.yahoo.com - March 9 at 6:54 PM
reuters.com logoBRIEF-Morgan Stanley reports 6.1 pct passive stake in Ophthotech- SEC Filing
www.reuters.com - March 8 at 8:41 PM
finance.yahoo.com logoINVESTOR COMPLAINT: Levi & Korsinsky, LLP Reminds Investors of Ophthotech Corporation of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 13, 2017
finance.yahoo.com - March 8 at 3:41 PM
finance.yahoo.com logoDEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Ophthotech Corporation (OPHT) & Lead Plaintiff Deadline: March 13, 2017
finance.yahoo.com - March 7 at 6:52 PM

Social

Chart

Ophthotech Corp (OPHT) Chart for Monday, May, 29, 2017

This page was last updated on 5/29/2017 by MarketBeat.com Staff